- Login
- Register & Subscribe
- Sprache: EN FR DE
Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.
The latest MedNous journal. Subscribe to download.
Free Featured Article
Thursday 2 February 2012
Country: United Kingdom
Citing the need to make further productivity gains, AstraZeneca Plc has announced plans to eliminate 7,300 jobs by the end of 2014 or about 12% of its 60,000-strong workforce. Of this number, 2,200 positions will be taken from research and development. This is the third company-wide restructuring programme since 2007 which altogether will see the loss of 28,900 jobs and yield annual savings estimated at $5.9 billion by the end of 2014.
Speaking to journalists on 2 February 2012, David Brennan, the chief executive, said that the single biggest issue facing the pharmaceutical industry today is a decline in R&D productivity. To address this head on, the company will aggressively cut back internal R&D posts and make its neuroscience division ‘virtual.’ Mr Brennan
Wednesday 1 February 2012
Country: United States
Tuesday 31 January 2012
Country: United States
Visit our news section for more articles.
MedNous is a print publication and a website for everyone involved in medical research in Europe.
The January 2012 MedNous features:
The latest MedNous journal. Subscribe to download.
Friday February 3 2012
Monday January 23 2012
Wednesday January 11 2012
Wednesday January 4 2012
Tuesday January 3 2012